Suppr超能文献

基于超声分级相关性对小儿肺炎旁胸腔积液进行纤溶剂量分层。

Stratifying fibrinolytic dosing in pediatric parapneumonic effusion based on ultrasound grade correlation.

作者信息

James Charles A, Braswell Leah E, Pezeshkmehr Amir H, Roberson Paula K, Parks James A, Moore Mary B

机构信息

Radiology Department, Arkansas Children's Hospital, University of Arkansas for Medical Sciences, 1 Children's Way, Slot 105, Little Rock, AR, 72202, USA.

Biostatistics Department, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

出版信息

Pediatr Radiol. 2017 Jan;47(1):89-95. doi: 10.1007/s00247-016-3711-y. Epub 2016 Oct 5.

Abstract

BACKGROUND

Complicated pleural effusion prolongs the hospital course of pneumonia. Chest tube placement with instillation of fibrinolytic medication allows efficient drain output and decreases hospital stay.

OBJECTIVE

To evaluate experience with lower fibrinolytic dose for parapneumonic effusions and to assess potential dose stratification based on a simple ultrasound grading system.

MATERIALS AND METHODS

We retrospectively reviewed the medical record to identify children and young adults who received fibrinolytic therapy for parapneumonic effusion and had chest tube placement by an interventional radiology service at a single children's hospital. We assessed tissue plasminogen activator (tPA) dosing and treatment duration, as well as the need for a second pleural procedure or surgical drainage. Diagnostic US images were classified as showing less than 50% pleural echogenicity (grade 1) or greater than 50% pleural echogenicity (grade 2) and were correlated with clinical parameters.

RESULTS

Of 32 patients with parapneumonic effusion, all except one received at least some 1-mg tPA doses. Dosing was solely 1-mg tPA in 81% of subjects; 19% of subjects also received 2-mg tPA doses. Mean fibrinolytic duration was 3.1 days for grade 1 effusions compared to 5.4 days for grade 2 effusions. A second pleural procedure was required in 15.6% of children. Pleural drainage with fibrinolytic therapy was successful in 97%; only one child required surgical drainage. Grade 2 US differed significantly from grade 1 US, with grade 2 occurring in younger patients (P < 0.0001), smaller patients (P < 0.0001), those needing a second procedure (P = 0.001), those with positive pleural culture or polymerase chain reaction test (P = 0.006), and those with longer treatment duration (P = 0.03).

CONCLUSION

A lower 1-mg dosing regimen of tissue plasminogen activator was effective in all children with less complex (grade 1 US imaging) parapneumonic effusions. Grade 2 US images correlated with younger and smaller children, presence of a pleural organism, and longer or more complicated chest tube duration.

摘要

背景

复杂性胸腔积液会延长肺炎患者的住院时间。放置胸腔引流管并注入纤溶药物可有效增加引流量并缩短住院时间。

目的

评估较低剂量纤溶药物治疗肺炎旁胸腔积液的经验,并基于简单的超声分级系统评估潜在的剂量分层。

材料与方法

我们回顾性分析病历,以确定在一家儿童医院接受介入放射科胸腔置管并接受纤溶治疗的肺炎旁胸腔积液患儿和青年成人。我们评估了组织纤溶酶原激活剂(tPA)的剂量和治疗持续时间,以及是否需要再次进行胸膜操作或手术引流。诊断性超声图像分为胸膜回声低于50%(1级)或高于50%(2级),并与临床参数相关联。

结果

在32例肺炎旁胸腔积液患者中,除1例患者外,其余均接受了至少一些1mg的tPA剂量。81%的受试者仅使用1mg的tPA剂量;19%的受试者还接受了2mg的tPA剂量。1级积液的平均纤溶治疗持续时间为3.1天,而2级积液为5.4天。15.6%的儿童需要再次进行胸膜操作。纤溶治疗胸腔引流成功率为97%;只有1名儿童需要手术引流。2级超声与1级超声有显著差异,2级出现在更年轻的患者中(P<0.0001)、更小的患者中(P<0.0001)、需要再次操作的患者中(P=0.001)、胸膜培养或聚合酶链反应检测呈阳性的患者中(P=0.006)以及治疗持续时间更长的患者中(P=0.03)。

结论

较低的1mg组织纤溶酶原激活剂给药方案对所有病情不太复杂(1级超声成像)的肺炎旁胸腔积液患儿均有效。2级超声图像与更年轻、更小的儿童、胸膜病原体的存在以及胸腔引流管留置时间更长或更复杂相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验